Department of Neurology, Movement Disorder Center, Neuroscience Research Institute, BK21, College of Medicine, Seoul National University Hospital, Seoul, Korea.
Neurosurgery. 2010 Sep;67(3):626-32; discussion 632. doi: 10.1227/01.NEU.0000374850.98949.D4.
Previous studies have shown that subthalamic nucleus (STN) deep brain stimulation (DBS) improves tremor in Parkinson disease (PD). However, the patients included in those studies were unselected for tremor severity.
We specifically assessed the effect of STN DBS on tremor in selected PD patients with severe tremor.
Seventy-two PD patients who had received bilateral STN DBS were included. The effects of STN DBS on the off-medication tremor, the on-medication tremor, and the off-medication action tremor in patients selected as the worst one-third in each category at baseline were evaluated after a mean duration of > 2 years.
In patients with severe off-medication tremor, off-medication tremor score improved from 12.28 +/- 2.80 at baseline to 1.93 +/- 2.85 at the last follow-up (P < .001). The off-medication tremor in the off-stimulation state at the last follow-up was less severe than the preoperative off-medication tremor. In patients with severe on-medication tremor, on-medication tremor score improved from 6.17 +/- 2.45 to 1.35 +/- 2.58 (P < .001). In patients with severe off-medication action tremor, off-medication action tremor score improved from 5.08 +/- 1.35 to 1.24 +/- 1.42 (P < .001).
STN DBS is effective for severe off- and on-medication tremor and off-medication action tremor in PD. Our findings suggest that STN DBS reduces PD tremor through, at least in part, its effect on the tremor-generating mechanism independent of dopaminergic transmission and that long-term electrical stimulation of STN might induce a structural or neurochemical change leading to the improvement of tremor.
先前的研究表明,丘脑底核(STN)深部脑刺激(DBS)可改善帕金森病(PD)患者的震颤。然而,这些研究纳入的患者并未针对震颤严重程度进行选择。
我们专门评估了 STN-DBS 对选择的震颤严重的 PD 患者震颤的影响。
纳入了 72 例接受双侧 STN-DBS 的 PD 患者。在平均 > 2 年的随访后,评估了 STN-DBS 对基线时每个类别中最差三分之一患者的药物治疗下震颤、药物治疗后震颤和药物治疗后动作性震颤的影响。
在震颤严重的患者中,药物治疗下震颤评分从基线时的 12.28±2.80 改善至末次随访时的 1.93±2.85(P<0.001)。末次随访时的刺激关闭状态下的药物治疗后震颤比术前药物治疗后震颤轻。在震颤严重的药物治疗后震颤患者中,药物治疗后震颤评分从 6.17±2.45 改善至 1.35±2.58(P<0.001)。在震颤严重的药物治疗后动作性震颤患者中,药物治疗后动作性震颤评分从 5.08±1.35 改善至 1.24±1.42(P<0.001)。
STN-DBS 对 PD 的严重药物治疗下和药物治疗后震颤以及药物治疗后动作性震颤有效。我们的发现表明,STN-DBS 通过至少部分地作用于与多巴胺能传递无关的震颤产生机制来减轻 PD 震颤,并且 STN 的长期电刺激可能导致结构或神经化学变化,从而改善震颤。